ArticleThe American journal of pathology2007

Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?

Marina Scheler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.